A CD4 count remaining below 500 was associated with an increased risk of death in a ten-year analysis from Poland. The study confirms that immune restoration – regardless of how long it takes – is a powerful predictor of survival in people with HIV who are on effective antiretroviral therapy (ART).
People with untreated HIV typically lose around 30 or 40 CD4 cells a year. Starting ART reverses this decline, but the size and speed and size of the increase in CD4 cells vary between people. The higher a person’s CD4 count when starting ART, the more likely that they will reach – or stay above – a CD4 count of 500.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] Gilead and Merck announce positive topline results from two Phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment
-
aidsmap: Switching to an integrase inhibitor can raise diabetes risk in people with HIV
-
TheBodyPro: Can long-acting regimens solve virologic failure in heavily treatment-experienced people with HIV?
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.